Amarin Corporation plc (ADR) (AMRN), GlaxoSmithKline plc (ADR) (GSK), Teva Pharmaceutical Industries Ltd (ADR) (TEVA): Will This Fishy Biotech Go Belly Up?
There are plenty of biotech companies that put all of their eggs in one basket these days.
Teva Pharmaceutical Industries Ltd (TEVA)
$16.48 -0.23 (-1.38%) Market is closed
News
- First
- << Previous
- 161 - 170
- Next >>
Trius Therapeutics, Inc. (TSRX), Cubist Pharmaceuticals Inc (CBST), Pfizer Inc. (PFE): A Portfolio Of Potential
After the market closed on July 30, antibiotic expert Cubist Pharmaceuticals Inc (NASDAQ:CBST) announced two acquisitions worth up to a combined $1.6 billion.
Celgene Corporation (CELG), Bristol-Myers Squibb Co (BMY): One Drug Dramatically Reshaping Pancreatic Cancer Treatment
A couple months may not seem like a long time, but when you're diagnosed with pancreatic cancer, the prospect of a few months makes a huge difference.
Amgen, Inc. (AMGN), Teva Pharmaceutical Industries Ltd (ADR) (TEVA): The Neulasta Question
In a couple of years, Amgen, Inc. (NASDAQ:AMGN) will have to face the music when the patent for its $4 billion a year drug, Neulasta, expires in the U.S. and Europe.
Ariad Pharmaceuticals, Inc. (ARIA), Pfizer Inc. (PFE), Novartis AG (ADR) (NVS): Does This Orphan Leukemia Treatment Have Blockbuster Potential?
When most biotech investors think of cancer treatments, they tend to think of large established players like Roche and Amgen.
Time Warner Inc (TWX), Netflix, Inc. (NFLX): Invest in Inelasticity
A couple of recent events got me thinking about price elasticity and how a savvy investor can capitalize on producers of inelastic products.
Microsoft Corporation (MSFT), Nokia Corporation (ADR) (NOK), Apple Inc. (AAPL): Low Expectations Are Wonderful Things
Since the time covered in last week's update, Microsoft Corporation (NASDAQ:MSFT) lost more in market value for the real-money Inflation-Protected Income Growth portfolio than any other stock in that...
Is Novo Nordisk A/S (ADR) (NVO) Going to Burn These Hedge Funds?
In the 21st century investor’s toolkit, there are a multitude of metrics investors can use to track Mr. Market. A couple of the most under-the-radar are hedge fund and insider trading movement.
Teva Pharmaceutical Industries Ltd (ADR) (TEVA): It's All About The Cold Hard Cash
This past week has been fairly brutal to stocks as the situation in Syria deteriorated and American saber-rattling suggested that a military intervention may be right around the corner.
Allergan, Inc. (AGN), Sanofi SA (ADR) (SNY): New FDA Guidelines Hit This Company Hard
Allergan, Inc. (NYSE:AGN), the diversified health care giant best known for Botox, boasts an impressive portfolio of products.
- First
- << Previous
- 161 - 170
- Next >>
Billionaire Hedge Funds
